Bayer Acquires Two Biocides
March 4, 2003
LEVERKUSEN, Germany and PITTSBURGH — In a transaction that was concluded with Ondeo Nalco Co., Bayer Corp., a 100-percent subsidiary of Bayer AG, acquired the EPA-registered active ingredients thiabendazole (TBZ) and dibromodicyanobutane (DBDCB), along with certain patent-protected formulations of these biocides in combination with other biocides. The acquisition, including the trade names Tektamer, Biochek and Metasol, expands and strengthens the well-established offerings of Bayer’s material-protection business.
For more information, visit http://www.bayer.com.